Seaport Therapeutics Management
Management criteria checks 2/4
Seaport Therapeutics' CEO is Daphne Zohar, appointed in Apr 2024, has a tenure of 2.25 years. total yearly compensation is $1.26M, comprised of 61% salary and 39% bonuses, including company stock and options. directly owns 2.23% of the company’s shares, worth $23.13M. The average tenure of the management team and the board of directors is 2.1 years and 2 years respectively.
Key information
Daphne Zohar
Chief executive officer
US$1.3m
Total compensation
| CEO salary percentage | 61.01% |
| CEO tenure | 2.3yrs |
| CEO ownership | 2.2% |
| Management average tenure | 2.1yrs |
| Board average tenure | 2yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2026 | n/a | n/a | -US$87m |
| Dec 31 2025 | US$1m | US$769k | -US$75m |
Compensation vs Market: Daphne's total compensation ($USD1.26M) is below average for companies of similar size in the US market ($USD3.54M).
Compensation vs Earnings: Insufficient data to compare Daphne's compensation with company performance.
CEO
Daphne Zohar (55 yo)
Ms. Daphne Zohar serves as Founder of Seaport Therapeutics, Inc. and serves as its Chief Executive Officer & Director from April 09, 2024 and serves as its President since April 09, 2024. She Founded PureT...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Non-Employee Chair of the Board | 2.3yrs | US$500.00k | 1.61% $ 16.7m | |
| Founder | 2.3yrs | US$1.26m | 2.23% $ 23.1m | |
| Co-Founder & Chief Scientific Officer | 2.2yrs | US$1.09m | 0.0063% $ 64.9k | |
| Chief Medical Officer & President of Clinical Development | 2.1yrs | US$670.25k | 0.038% $ 389.6k | |
| Chief Financial Officer | 1.7yrs | no data | no data | |
| General Counsel | 2.1yrs | no data | no data |
Experienced Management: SPTX's management team is considered experienced (2.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Non-Employee Chair of the Board | 2.3yrs | US$500.00k | 1.61% $ 16.7m | |
| Founder | 2.3yrs | US$1.26m | 2.23% $ 23.1m | |
| Independent Non-Employee Director | 2.3yrs | no data | no data | |
| Independent Non-Employee Director | 1.7yrs | US$35.00k | 0% $ 0 | |
| Independent Non-Employee Director | less than a year | no data | no data | |
| Independent Non-Employee Director | 1.3yrs | US$462.24k | 0.024% $ 251.9k | |
| Independent Non-Employee Director | 2yrs | US$35.00k | 0% $ 0 | |
| Independent Non-Employee Director | 2.2yrs | US$35.00k | 0.025% $ 259.6k | |
| Independent Non-Employee Director | 1.8yrs | no data | no data |
Experienced Board: SPTX's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/07 21:40 |
| End of Day Share Price | 2026/07/07 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Seaport Therapeutics, Inc. is covered by 5 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yigal Nochomovitz | Citigroup Inc |
| Salveen Richter | Goldman Sachs |
| Tessa Romero | J.P. Morgan |